Home  |  Contact

UniProtKB/Swiss-Prot P19367: Variant p.Glu847Lys

Hexokinase-1
Gene: HK1
Variant information

Variant position:  847
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  US
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Glutamate (E) to Lysine (K) at position 847 (E847K, p.Glu847Lys).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and acidic (E) to large size and basic (K)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In RP79; unknown pathological significance; no effect on hexokinase activity; no effect on protein abundance.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  847
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  917
The length of the canonical sequence.

Location on the sequence:   SRRAAQLCGAGMAAVVDKIR  E NRGLDRLNVTVGVDGTLYKL
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         SRRAAQLCGAGMAAVVDKIRENRGLDRLNVTVGVDGTLYKL

Mouse                         SKRAAQLCGAGMAAVVEKIRENRGLDHLNVTVGVDGTLYKL

Rat                           SKRAAQLCGAGMAAVVEKIRENRGLDHLNVTVGVDGTLYKL

Bovine                        SKRAAQLCGAGMAAVVEKIRENRGLDRLNVTVGVDGTLYKL

Drosophila                    TNRAAMLVASGVSCLIDRMRLP------QISIAVDGGIYRL

Fission yeast                 GTRSARLSACGVCALVRKMNKP------SMIVGTDGSVYNL

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 917 Hexokinase-1
Domain 464 – 906 Hexokinase 2
Region 656 – 895 Hexokinase large subdomain 2
Helix 813 – 848


Literature citations

A dominant mutation in hexokinase 1 (HK1) causes retinitis pigmentosa.
Sullivan L.S.; Koboldt D.C.; Bowne S.J.; Lang S.; Blanton S.H.; Cadena E.; Avery C.E.; Lewis R.A.; Webb-Jones K.; Wheaton D.H.; Birch D.G.; Coussa R.; Ren H.; Lopez I.; Chakarova C.; Koenekoop R.K.; Garcia C.A.; Fulton R.S.; Wilson R.K.; Weinstock G.M.; Daiger S.P.;
Invest. Ophthalmol. Vis. Sci. 55:7147-7158(2014)
Cited for: INVOLVEMENT IN RP79; VARIANT RP79 LYS-847;

A missense mutation in HK1 leads to autosomal dominant retinitis pigmentosa.
Wang F.; Wang Y.; Zhang B.; Zhao L.; Lyubasyuk V.; Wang K.; Xu M.; Li Y.; Wu F.; Wen C.; Bernstein P.S.; Lin D.; Zhu S.; Wang H.; Zhang K.; Chen R.;
Invest. Ophthalmol. Vis. Sci. 55:7159-7164(2014)
Cited for: INVOLVEMENT IN RP79; VARIANT RP79 LYS-847; CHARACTERIZATION OF VARIANT RP79 LYS-847; FUNCTION;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.